UK affirms Pfizer’s COVID-19 immunization: When will it come to India and all different inquiries replied Kumar Jeetendra | December 2, 2020 The UK has become the first country to authorise the Pfizer-BioNTech COVID-19 vaccine for use. Here is everything you need to know about this vaccine candidate and much more Is India in discussions with Pfizer? Yes. According to the health ministry, its National Expert Group on Vaccine Administration for COVID-19 was in discussions with”all candidate …
Nevada statistician discovers improved way to classify obesity: Move away BMI! Welcome BFI Kumar Jeetendra | December 2, 2020 Body Mass Index, or BMI, is a universal index to classify obesity. One of BMI’s limitations is that it can’t differentiate between muscle and fat, so even Olympic athletes can be classified as obese. On the other end, people with high levels of visceral fat who are at significant health risk can pass entirely under …
Risk of Lung cancer among passive smokers Kumar Jeetendra | November 30, 2020 Cancer is a deadly disease and lung cancer is one of the most common cause of cancer related deaths worldwide. Approximately 11-12% of all cancer cases worldwide are lung cancers. In India about 70,000 new lung cases are diagnosed every year which comprises of approx. 6-7% of all cancer cases. Tobacco consumption is the significant …
Novel method to detect single coronavirus particles Kumar Jeetendra | November 28, 2020 Scientists have developed a new method for identifying single virus particles based on changes in electrical current when they pass through ultrasmall pores, an advance which they claim may lead to new rapid COVID-19 tests. The study, published in the journal ACS Sensors, demonstrated a new system for identifying single virus particles using an algorithm …
Heparan Sulfate Products for COVID-19 Infection, Disease & Therapeutics Research Kumar Jeetendra | November 26, 2020 Heparan Sulfate (HS) is increasingly recognised as a key factor in infection by the SARS-CoV-2 virus, which is the cause of the current COVID-19 Coronavirus pandemic. Using HS antibodies from AMSBIO, researchers have demonstrated that Heparanase enzyme contributes to the pathogenesis of COVID-19, with both Heparanase activity and HS levels being elevated in plasma of …
Researchers grow first plant-based gel to help organoid development for biomedical applications Kumar Jeetendra | November 26, 2020 Monash University researchers have created the world’s first bioactive plant-based nanocellulose hydrogel to support organoid growth and help significantly reduce the costs of research into cancer and COVID-19. This discovery by researchers in BioPRIA (Bioresource Processing Institute of Australia), Monash University’s Department of Chemical Engineering and the Monash Biomedicine Discovery Institute will develop organoids cheaper, …
Biocompatible photooxygenation catalyst could be conceivably used to treat amyloid infections Kumar Jeetendra | November 26, 2020 The catalyst was able to oxygenate Aβ embedded beneath the skin of a living mouse, and diminished intact Aβ degree in AD-model mouse brain. The new catalyst is potentially useful for the treatment of peripheral amyloid diseases and AD. Toxic aggregation of amyloid peptide and protein is closely associated with a number of human diseases. …
Study uncovers a quality answerable for anthraquinone synthesis in plants Kumar Jeetendra | November 25, 2020 Anthraquinones are a class of naturally occurring chemicals prized for their medicinal properties, as well as for other programs, including ecologically friendly dyes. Despite broad interest, the mechanism by which plants produce them has remained shrouded in mystery until today. New work from an international group of scientists including Carnegie’s Sue Rhee shows a gene …
China National Biotec Group Co. (CNBG), a leading vaccine developer has sought authorisation to bring its COVID-19 candidate to the current market Kumar Jeetendra | November 25, 2020 China National Biotec Group Co. (CNBG), a leading vaccine developer has sought authorisation to bring its COVID-19 candidate to the current market, Bloomberg has reported. The Bloomberg report cites Shi Shengyi, the vice general director of Sinopharm — CNBG’s parent company — as saying that an application in this regard was submitted to Chinese regulators …
University of Sheffield and Pfizer dispatch new consortium to quicken improvement of ATMPs Kumar Jeetendra | November 24, 2020 The University of Sheffield and Pfizer have today (23 November 2020) established a new consortium which aims to standardize and accelerate the growth of Advanced Therapy Medicinal Products (ATMPs), allowing potentially transformative remedies to reach patients sooner. The new, five-year consortium, Accelerating Research and Innovation for Advanced Therapies (ARDAT), is supported by the Innovative Medicines …
Patients’ own stem cells can be utilized to develop new bones, study shows Kumar Jeetendra | November 23, 2020 A new, groundbreaking study from the University of Bergen (UiB) shows that a patients’ own stem cells can be used to grow new bone. This can potentially help millions of people who are partially edentulous and have inadequate bone for placement of dental implants. The Maxibone Project, coordinated by Pierre Layrolle, Inserm, University of Nantes, …
AstraZeneca begins new COVID-19 anticipation preliminaries of antibody cocktail Kumar Jeetendra | November 21, 2020 AstraZeneca started late-stage trials on November 21 of an experimental long-acting monoclonal antibody combination drug it hopes could be utilised as a so-called prophylactic to prevent COVID-19 infection in at-risk individuals for up to 12 months. The Phase III global clinical trial will recruit a total of 5,000 people across countries in Europe and the …
